Gefitinib Tablets

Gefitinib is a medication classified as a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer (NSCLC) that carries specific mutations in the epidermal growth factor receptor (EGFR).

It works by targeting and inhibiting certain proteins involved in cancer cell growth, particularly those associated with the EGFR pathway. By blocking these signals, gefitinib helps to slow down or halt the growth of cancer cells.

Gefitinib is typically taken orally in tablet form and is prescribed by a healthcare provider. The dosage and duration of treatment depend on various factors, including the individual’s health condition and the specific type and stage of cancer.